A detailed history of State Street Corp transactions in Chimerix Inc stock. As of the latest transaction made, State Street Corp holds 297,780 shares of CMRX stock, worth $262,046. This represents 0.0% of its overall portfolio holdings.

Number of Shares
297,780
Previous 297,780 -0.0%
Holding current value
$262,046
Previous $262,000 5.34%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.87 - $1.05 $2,610 - $3,150
3,000 Added 1.02%
297,780 $262,000
Q1 2024

May 15, 2024

SELL
$0.91 - $1.26 $7,462 - $10,332
-8,200 Reduced 2.71%
294,780 $312,000
Q3 2023

Nov 14, 2023

SELL
$0.94 - $1.23 $49,227 - $64,415
-52,370 Reduced 14.74%
302,980 $290,000
Q2 2023

Aug 14, 2023

SELL
$1.1 - $1.54 $2.13 Million - $2.99 Million
-1,939,749 Reduced 84.52%
355,350 $429,000
Q1 2023

May 15, 2023

SELL
$1.19 - $2.09 $45,416 - $79,764
-38,165 Reduced 1.64%
2,295,099 $2.89 Million
Q4 2022

Feb 14, 2023

SELL
$1.67 - $2.35 $969,373 - $1.36 Million
-580,463 Reduced 19.92%
2,333,264 $4.34 Million
Q3 2022

Nov 15, 2022

BUY
$1.81 - $2.76 $1.62 Million - $2.46 Million
892,726 Added 44.17%
2,913,727 $5.62 Million
Q2 2022

Aug 15, 2022

SELL
$1.34 - $5.34 $3.4 Million - $13.6 Million
-2,540,867 Reduced 55.7%
2,021,001 $4.2 Million
Q1 2022

May 16, 2022

BUY
$4.58 - $6.8 $2.6 Million - $3.87 Million
568,498 Added 14.24%
4,561,868 $20.9 Million
Q4 2021

Feb 14, 2022

BUY
$5.23 - $7.18 $1.42 Million - $1.96 Million
272,391 Added 7.32%
3,993,370 $25.7 Million
Q3 2021

Nov 15, 2021

BUY
$5.94 - $8.75 $3.01 Million - $4.44 Million
507,499 Added 15.79%
3,720,979 $23 Million
Q2 2021

Aug 16, 2021

BUY
$7.54 - $9.79 $2.43 Million - $3.16 Million
322,518 Added 11.16%
3,213,480 $25.7 Million
Q1 2021

May 17, 2021

BUY
$4.76 - $11.25 $8.85 Million - $20.9 Million
1,858,328 Added 179.96%
2,890,962 $27.9 Million
Q4 2020

Feb 16, 2021

SELL
$2.43 - $5.42 $1,686 - $3,761
-694 Reduced 0.07%
1,032,634 $4.99 Million
Q3 2020

Nov 10, 2020

SELL
$2.3 - $3.72 $82,717 - $133,786
-35,964 Reduced 3.36%
1,033,328 $2.57 Million
Q2 2020

Aug 14, 2020

SELL
$1.33 - $3.63 $229,726 - $626,999
-172,727 Reduced 13.91%
1,069,292 $3.32 Million
Q1 2020

May 11, 2020

BUY
$1.27 - $2.33 $1.58 Million - $2.89 Million
1,242,019 New
1,242,019 $1.79 Million

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $77.1M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.